EyePoint Pharmaceuticals
EYPT
EYPT
59 hedge funds and large institutions have $200M invested in EyePoint Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 17 increasing their positions, 4 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
84% more funds holding
Funds holding: 32 → 59 (+27)
14.95% more ownership
Funds ownership: 53.68% → 68.63% (+15%)
Holders
59
Holding in Top 10
2
Calls
$3.42M
Puts
$777K
Top Buyers
| 1 | +$15.4M | |
| 2 | +$15M | |
| 3 | +$12.7M | |
| 4 |
SCM
Suvretta Capital Management
New York
|
+$12M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$10.4M |
Top Sellers
| 1 | -$4.61M | |
| 2 | -$980K | |
| 3 | -$685K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$186K |
| 5 |
Squarepoint
New York
|
-$107K |